Cobalt chloride inhibits tumor formation in osteosarcoma cells through upregulation of HIF-1α

Zhang,Bo; Guo,Weichun; Yu,Ling; Wang,Fu'an; Xu,Yong; Liu,Yang; Huang,Chengxiao

doi:10.3892/ol.2013.1127

Cobalt chloride inhibits tumor formation in osteosarcoma cells through upregulation of HIF-1α

Authors:
- Bo Zhang
- Weichun Guo
- Ling Yu
- Fu'an Wang
- Yong Xu
- Yang Liu
- Chengxiao Huang
View Affiliations

Affiliations: Department of Orthopedics, Renmin Hospital, Wuhan University, Wuhan 430060, P.R. China
Published online on: January 10, 2013 https://doi.org/10.3892/ol.2013.1127
Pages: 911-916

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The exact effect of hypoxia on cancer development is controversial. The present study investigates the ability of osteosarcoma to form tumors in the hypoxic microenvironment induced by CoCl2. MG63 human osteosarcoma cells were cultured with different concentrations (0, 150 and 300 µM) of CoCl2 for 24 h to simulate hypoxia in vitro. The expression of hypoxia-inducible factor (HIF)-1α was analyzed by western blotting. The proliferation and drug resistance of MG63 cells were examined using the CCK-8 assay, the apoptosis rate was detected by flow cytometry, the ability to form spheroids was assessed by a sarcosphere culture system and invasiveness was determined by a vertical invasion assay. A transplantation assay was used to evaluate the ability to form tumors in vivo. Our results showed that the proliferation of MG63 cells was inhibited by treatment with CoCl2, while no effect on drug toxicity was observed. The apoptotic rate was increased in a dose-dependent manner, the ability to form sarcospheroids was suppressed, the invasiveness was inhibited and the expression of HIF-1α was upregulated following CoCl2 treatment. We also found that the ability to form tumors in vivo was inhibited. In conclusion, we provide strong evidence that CoCl2 has the ability to inhibit osteosarcoma development; the mechanism may be related to the hypoxic microenvironment and HIF-1α may be a critical regulatory factor.

View Figures

View References

1	Ritter J and Bielack SS: Osteosarcoma. Ann Oncol. 21(Suppl 7): vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
2	Steliarova-Foucher E, Stiller C, Lacour B and Kaatsch P: International Classification of Childhood Cancer, third edition. Cancer. 103:1457–1467. 2005. View Article : Google Scholar : PubMed/NCBI
3	Fletcher CDM, Unni KK and Mertens F: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press; Lyon, France: pp. 2252002
4	Ottaviani G and Jaffe N: The epidemiology of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
5	Geller DS and Gorlick R: Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
6	Trédan O, Galmarini CM, Patel K and Tannock IF: Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 99:1441–1454. 2007.
7	Thomlinson RH: Hypoxia and tumours. J Clin Pathol Suppl. 11:105–113. 1977. View Article : Google Scholar : PubMed/NCBI
8	Semenza GL and Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 12:5447–5454. 1992.PubMed/NCBI
9	Wang PP, Kong FP, Chen XQ and Du JZ: HIF-1 signal pathway in cellular response to hypoxia. Zhejiang Da Xue Xue Bao Yi Xue Ban. 40:559–566. 2011.(In Chinese).
10	Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:485–490. 1998. View Article : Google Scholar : PubMed/NCBI
11	Piret JP, Mottet D, Raes M and Michiels C: CoCl₂, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann NY Acad Sci. 973:443–447. 2002.PubMed/NCBI
12	Goldberg MA and Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem. 269:4355–4359. 1994.PubMed/NCBI
13	Brehmer F, Bendix I, Prager S, van de Looij Y, Reinboth BS, Zimmermanns J, Schlager GW, Brait D, Sifringer M, Endesfelder S, Sizonenko S, Mallard C, Bührer C, Felderhoff-Mueser U and Gerstner B: Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage. PLoS One. 7:e490232012. View Article : Google Scholar : PubMed/NCBI
14	Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
15	Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL: The expression and distribution of the hypoxia inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers and tumor-associated macrophages. Am J Pathol. 157:411–421. 2000. View Article : Google Scholar : PubMed/NCBI
16	Covello KL, Simon MC and Keith B: Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor-2alpha knock-in allele promotes tumor growth. Cancer Res. 65:2277–2286. 2005. View Article : Google Scholar : PubMed/NCBI
17	Pérez-Sayáns M, Suárez-Peñaranda JM, Pilar GD, Barros-Angueira F, Gándara-Rey JM and García-García A: Hypoxia-inducible factors in OSCC. Cancer Lett. 313:1–8. 2011.
18	Andrikopoulou E, Zhang X, Sebastian R, Marti G, Liu L, Milner SM and Harmon JW: Current insights into the role of HIF-1 in cutaneous wound healing. Curr Mol Med. 11:218–235. 2011. View Article : Google Scholar : PubMed/NCBI
19	Chouaib S, Messai Y, Couve S, Escudier B, Hasmim M and Noman MZ: Hypoxia promotes tumor growth in linking angiogenesis to immune escape. Front Immunol. 3:212012. View Article : Google Scholar : PubMed/NCBI
20	Dai S, Huang ML, Hsu CY and Chao KS: Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells. Int J Radiat Oncol Biol Phys. 55:1027–1036. 2003. View Article : Google Scholar
21	Xing D, Sun X, Li J, Cui M, Tan-Allen K and Bonanno JA: Hypoxia preconditioning protects corneal stromal cells against induced apoptosis. Exp Eye Res. 82:780–787. 2006. View Article : Google Scholar : PubMed/NCBI
22	Akakura N, Kobayashi M, Horiuchi I, Suzuki A, Wang J, Chen J, Niizeki H, Kawamura Ki, Hosokawa M and Asaka M: Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61:6548–6554. 2001.
23	Dai ZJ, Gao J, Ma XB, Yan K, Liu XX, Kang HF, Ji ZZ, Guan HT and Wang XJ: Up-regulation of hypoxia inducible factor-1α by cobalt chloride correlates with proliferation and apoptosis in PC-2 cells. J Exp Clin Cancer Res. 31:282012.
24	Ardyanto TD OM, Tokuyasu N, Nagahama Y and Ito H: CoCl_2⁻ induced HIF-1alpha expression correlates with proliferation and apoptosis in MKN-1 cells: a possible role for the PI3K/Akt pathway. Int J Oncol. 29:549–555. 2006.
25	Yang SJ, Pyen J, Lee I, Lee H, Kim Y and Kim T: Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells. J Biochem Mol Biol. 37:480–486. 2004. View Article : Google Scholar : PubMed/NCBI
26	Brahimi-Horn C and Pouyssegur J: The role of the hypoxiainducible factor in tumor metabolism growth and invasion. Bull Cancer. 93:E73–80. 2006.PubMed/NCBI
27	Cowden Dahl KD, Robertson SE, Weaver VM and Simon MC: Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. Mol Biol Cell. 16:1901–1912. 2005.PubMed/NCBI
28	Kalpana S, Dhananjay S, Anju B, Lilly G and Sai Ram M: Cobalt chloride attenuates hypobaric hypoxia induced vascular leakage in rat brain: molecular mechanisms of action of cobalt chloride. Toxicol Appl Pharmacol. 231:354–363. 2008. View Article : Google Scholar : PubMed/NCBI
29	Dalerba P, Cho RW and Clarke MF: Cancer stem cells: models and concepts. Ann Rev Med. 58:267–284. 2007. View Article : Google Scholar : PubMed/NCBI
30	Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006. View Article : Google Scholar
31	Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and Steindler DA: Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
32	Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K and Takakura Y: Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol. 34:1381–1386. 2009.PubMed/NCBI
33	Borenstein X, Fiszman GL, Blidner A, Vanzulli SI and Jasnis MA: Functional changes in murine mammary cancer cells elicited by CoCl₂-induced hypoxia. Nitric Oxide. 23:234–241. 2010. View Article : Google Scholar : PubMed/NCBI